中文 | English
Return
Total: 8535 , 1/854
Show Home Prev Next End page: GO
Author:(Hua CHEN)

1.Ethical Study on Commercial Bribery in Pharmaceutical field

Hua CHEN ;

Chinese Medical Ethics 1994;0(05):-

2.Curative Effect of Atorvastatin Intensive Treatment on Lipid-Lowering in Patients with Type 2 Diabetes and Its Influence on Vascular Endothelial Function

Chen HUA

China Pharmacist 2015;(11):1944-1946

3.Relieve Physician-Patient Conflicts and Construct a Harmonious Physician-Patient Relationship——Take the Case in Guangzhou City as an Example

Hua CHEN

Chinese Medical Ethics 1995;0(03):-

4.Ethical Review on the Medical Default in the Context of Informed Disconsent

Hua CHEN

Chinese Medical Ethics 1994;0(06):-

5.Cellular immunologic characteristics of super severe combined immunodeficient mice

Hua CHEN

Chinese Journal of Immunology 1985;0(02):-

6.The Ethical Ponderation On Over-treatment Caused by Onus Proof of Conversion

Hua CHEN

Chinese Medical Ethics 1995;0(02):-

7.Intervention of Irbesartan in Treatment of Early Diabetic Nephropathy in the Normotensive Aged Patients

Hua CHEN

Journal of Chinese Physician 2000;0(11):-

8.Application of Mental Intervention in the Treatment of Childen's Functional Recurrent Abdominal Pain

Hua CHEN

Journal of Zhejiang Chinese Medical University 2006;0(03):-

9.Professional Entrance and Management of Professional Titles of Pharmaceutical Technicians

Mingying CHEN ; Hua CHEN

China Pharmacy 2005;0(22):-

10.Management and Use of Protein Anabolic Preparation and Peptide Hormone in Our Hospital

Mingying CHEN ; Hua CHEN

China Pharmacy 2007;0(25):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 8535 , 1/854 Show Home Prev Next End page: GO